Cambridge Investment Research Advisors »

Milestone Pharmaceuticals shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $25k 13k 1.97

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Milestone Pharmaceuticals

Adage Capital Partners GP
Propel Bio Management
OrbiMed Advisors
Simplify Asset Management
Rtw Investments
Pathstone Holdings
Morgan Stanley
Sphera Funds Management
Toronto-Dominion Bank
Affinity Asset Advisors
Boxer Capital Management
Two Sigma Investments
Lion Point Capital
Citadel Advisors
Susquehanna International

View all funds holding Milestone Pharmaceuticals